Abstract
To the Editor: Nummular dermatitis is an idiopathic eczematous eruption characterized by pruritic, coin-shaped lesions typically involving the extremities and, less commonly, the trunk. Although topical therapy is the mainstay of management, treatment escalation may be required in severe cases. Dupilumab is a human monoclonal antibody against the interleukin 4 receptor α subunit that has shown efficacy for moderate to severe atopic dermatitis.1 We present a retrospective cohort study of our institutional experience with dupilumab for nummular dermatitis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
